MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...
Bristol Myers Squibb's Opdivo has been approved in a subcutaneous injection formulation by the FDA, making treatment easier for patients and potentially adding years to the product's patent life.
Thankfully, 2026 could be a much better year for the Denmark-based drugmaker. Let's consider two tailwinds that could help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback